ESC Professional Premium Access

Prognostic value and determinants of high sensitive cardiac Troponin levels in patients with a systemic right ventricle: insights from the SERVE-Trial

Congress Presentation

About the speaker

Doctor Francisco Javier Ruperti Repilado

University Hospital Basel, Basel (Switzerland)
2 presentations
1 follower

6 more presentations in this session

Safety and efficacy of apixaban for the prevention of thromboembolism in adults with congenital heart disease and atrial arrhythmias: a prospective cohort study with historical control comparison

Speaker: Doctor A. Kartas (Thessaloniki, GR)


Dapaglifozin in adults with a systemic right ventricle:initial results from the DAPA-SERVE trial

Speaker: Doctor M. Abbate (Naples, IT)


Evaluating the safety and long-term efficacy of triple vasodilator therapy for pulmonary arterial hypertension associated with congenital heart disease

Speaker: Doctor R. Luna (Barcelona, ES)


Adults with congenital heart disease and pulmonary arterial hypertension: Quantitative assessment of haemodynamic parameters under disease targeting therapy - A retrospective multicentre analysis

Speaker: Doctor P. von Stein (Cologne, DE)


Efficacy of intravenous iron therapy compared to usual treatment in iron deficient adult cyanotic congenital heart disease patients for improvement in clinical outcomes at three months

Speaker: Assistant Professor Z. Abdullah (New Delhi, IN)


Access the full session

Pharmacotherapy and biomarkers in adult congenital heart disease: do the same rules apply?

Speakers: Doctor F. Ruperti Repilado, Doctor A. Kartas, Doctor M. Abbate, Doctor R. Luna, Doctor P. von Stein...

About the event


ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by